Vnitr Lek 1988, 34(11):1122-1124
[Pyruvate kinase, 2,3 bisphosphoglycerate and fibrin-fibrinogen degradation products in patients with polycythemia, before and after erythrapheresis therapy].
Klíčová slova: 2,3-Diphosphoglycerate; Blood Component Removal; Diphosphoglyceric Acids, blood, ; Erythrocyte Transfusion; Female; Fibrin Fibrinogen Degradation Products, analysis, ; Humans; Male; Middle Aged; Polycythemia, blood, ; Pyruvate Kinase, blood,
Keywords: 2,3-Diphosphoglycerate; Blood Component Removal; Diphosphoglyceric Acids /blood/; Erythrocyte Transfusion; Female; Fibrin Fibrinogen Degradation Products /analysis/; Humans; Male; Middle Aged; Polycythemia /blood/; Pyruvate Kinase /blood/
Zveřejněno: 1. listopad 1988 Zobrazit citaci
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |